Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg-negative patients

被引:0
|
作者
Chen, E-Q. [1 ]
Wang, M-L. [1 ]
Wu, D-B. [1 ]
Liao, J. [1 ]
Tang, H. [1 ]
机构
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Sichuan, Peoples R China
关键词
CHRONIC HEPATITIS-B;
D O I
10.1111/apt.14815
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:236 / 237
页数:2
相关论文
共 50 条
  • [21] Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels
    Manesis, Emanuel K.
    Hadziyannis, Emilia S.
    Angelopoulou, Olga P.
    Hadziyannis, Stephanos J.
    ANTIVIRAL THERAPY, 2007, 12 (01) : 73 - 82
  • [22] Key mutations in HBsAg C-terminus correlate with lower HBsAg levels in vivo, hinder HBsAg release in vitro and affect HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection
    Piermatteo, L.
    Battisti, A.
    Carioti, L.
    Anastasiou, O.
    Gill, U. S.
    Colagrossi, L.
    Bertoli, A.
    Aragri, M.
    Iuvara, A.
    Malagnino, V.
    Cerva, C.
    Lichtner, M.
    Mastroianni, C. M.
    De Sanctis, G. M.
    Maurizio, P.
    Marignani, M.
    Pasquazzi, C.
    Iapadre, N.
    Mari, T.
    Parruti, G.
    Vecchiet, J.
    Sarmati, L.
    Andreoni, M.
    Mario, A.
    Grelli, S.
    Kennedy, P.
    Verheyen, J.
    Silberstein, F. Ceccherini
    Perno, C. F.
    Salpini, R.
    Svicher, V.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E60 - E60
  • [23] Key mutational patterns in HBsAg C-terminus profoundly affect HBsAg levels in HBeAg-negative chronic HBV genotype D infection
    Salpini, R.
    Battisti, A.
    Carioti, L.
    Carlo, D. D.
    Anastasiou, O.
    Gill, U. S.
    Colagrossi, L.
    Bertoli, A.
    Aragri, M.
    Fabeni, L.
    Fini, V.
    Piermatteo, L.
    Iuvara, A.
    Malagnino, V.
    Cerva, C.
    Lichtner, M.
    Mastroianni, C. M.
    Sanctis, G. M. D.
    Maurizio, P.
    Marignani, M.
    Pasquazzi, C.
    Iapadre, N.
    Mari, T.
    Parruti, G.
    Vecchiet, J.
    Sarmati, L.
    Andreoni, M.
    Angelico, M.
    Grelli, S.
    Kennedy, P.
    Verheyen, J.
    Silberstein, F. C.
    Perno, C. F.
    Svicher, V.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S492 - S493
  • [24] RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE CHB: BASELINE AND ON-TREATMENT KINETICS OF HBSAG SERUM LEVELS VARY ACCORDING TO HBV GENOTYPE
    Brunetto, Maurizia R.
    Marcellin, Patrick
    Cherubini, Beatrice
    Yurdaydin, Cihan
    Farci, Patrizia
    Hadziyannis, Stephanos J.
    Rothe, Vivien
    Regep, Loredana
    Kapprell, Hans-Peter
    Bonino, Ferruccio
    HEPATOLOGY, 2011, 54 : 1059A - 1059A
  • [25] Basal core promotor (BCP) and precore mutations, HBV genotype or serum HBV DNA levels do not allow to distinguish true inactive HBsAg carriers from HBeAg negative chronic hepatitis B with fluctuating ALT
    Martinot-Peignoux, M
    Boyer, N
    Pham, BN
    Kumas, C
    Esnault, V
    Degott, C
    Marcellin, P
    JOURNAL OF HEPATOLOGY, 2004, 40 : 112 - 112
  • [26] EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS
    Rijckborst, V.
    Hansenu, B. E.
    Cakaloglu, Y.
    Ferenci, P.
    Tabak, F.
    Akdogan, M.
    Simon, K.
    Akarca, U. S.
    Flisiak, R.
    Verhey, E.
    van Vuuren, A. J.
    Boucher, C. A. B.
    ter Borg, M. J.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S4 - S5
  • [27] HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
    Sonneveld, Milan J.
    Chiu, Shao-Ming
    Park, Jun Yong
    Brakenhoff, Sylvia M.
    Kaewdech, Apichat
    Seto, Wai-Kay
    Tanaka, Yasuhito
    Carey, Ivana
    Papatheodoridi, Margarita
    Colombatto, Piero
    van Bommel, Florian
    Janssen, Harry L.
    Berg, Thomas
    Zoulim, Fabien
    Ahn, Sang Hoon
    Dalekos, George N.
    Erler, Nicole S.
    Brunetto, Maurizia
    Wedemeyer, Heiner
    Cornberg, Markus
    Yuen, Man-Fung
    Agarwal, Kosh
    Boonstra, Andre
    Buti, Maria
    Piratvisuth, Teerha
    Papatheodoridis, George
    Chen, Chien-Hung
    Maasoumy, Benjamin
    GASTROENTEROLOGY, 2024, 166 (01) : 168 - 177.e8
  • [28] Analysis of pathological changes and related factors in liver tissue of HBeAg-negative patients with low HBsAg levels
    Li Liu
    Chunyun Liu
    Junyi Li
    Yingrong Du
    Jie Chen
    Hui Wang
    Huimin Li
    Lixian Chang
    Clinical and Experimental Medicine, 2020, 20 : 577 - 586
  • [29] Analysis of pathological changes and related factors in liver tissue of HBeAg-negative patients with low HBsAg levels
    Liu, Li
    Liu, Chunyun
    Li, Junyi
    Du, Yingrong
    Chen, Jie
    Wang, Hui
    Li, Huimin
    Chang, Lixian
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (04) : 577 - 586
  • [30] Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
    Ahmed, Fatima A.
    Bajaifar, Maryam S.
    Ahmed, Mohammed A.
    Alalwan, Abduljaleel
    Sanai, Faraaz A.
    Albeladi, Khalid
    Aljumah, Abdulrahman A.
    Sanai, Faisal M.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2019, 25 (05): : 286 - 292